EGFR and cancer: However, more recent findings have reported non-mutational mechanisms of drug resistance [10], such as the existence of a small fraction of drug refractory cancer stem cells [11], epigenetic mechanisms [12], and the emergence of drug tolerant persisters (DTPs) [[13], [14], [15]], and the activation of epidermal growth factor receptor (EGFR) signaling network.